April 10, 2008

Takeda Pharmaceutical Company Limited

Notice regarding Acquisition of the Company’s own shares
(Under the provisions of Articles of Incorporation
pursuant to Article 165 (2) of the Corporation Law of Japan)

OSAKA, Japan, April 10, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced that its Board of Directors resolved today acquisition of its own shares under Article 156 of the Corporation Law of Japan, as applied pursuant to Article 165 (3) of the Corporation Law, as detailed below:

1. Reason for acquisition of its own shares

For the purpose of improvement of capital efficiency, and promotion of expeditious financial strategies in accordance with the business environment.

2. Details of acquisition

(1) Class of shares to be acquired:	Shares of common stock
(2) Number of shares to be acquired:	Up to 11 million shares
	(equivalent to 1.24% of a total of issued shares)
(3) Total amount of shares to be acquired:	Up to 60 billion Yen
(4) Schedule of acquisition:	From April 11, 2008 to April 28, 2008

# # #